bluuebunny/crossref_metadata_2025_split huggingface dataset:
P02-268 - Impating Spiritual Practices Enhances Recovery from Anxiety Related Disorder
Authors: Acharya A. 
Published: June 2010

IntroductionIn 1808 German physician coins the term “Psychiatry”. Before that Doctors treating mental patients were termed “‘Allienist Doctor”, as the patients were kept in allination in that era. Before that in ancient times Hippcrates 460-377B.C identify epilepsy derives from brain, Plato387B.C teaches brain is the seat of mental disorders. Philophers or the religious monks tackled the behavioral problems or wories or the hopelessnes of suffered soul by their deeper insight as to the cause of sorrow or sufferings and the way towards relief from them. Lord Buddha Founder of Buddhisim admitted “Attachement is the cause of all evils”. Bhagbat geeta the epic of Hindu myhthology teaces on an unattached form of work, dperform the works as duty and never impart “self sensce”. as the They echoed on indefinity of soul in the life & which cannot be destroyed by fire, death or hit by any way. The seat of a divine soul inside the human body makes the definite body “infinity”.ObjectivesAmalgammation of spiritual ideas and practices may help in the recovery of minor mental stresses & some disorders Is ascertained here.Methods72 patients (44 male & 28 females in the age range of 24-46,. ), those were suffering from anxiety disorders GAD and Ac. Panic disorders were mached against an equal number of other 72 patents as per ICD_10.1st group recieves spiritual philoshopy and practices for 10 minuteseach day.ResultsFast recovery & sustainicity in the 1st gr.were observed against the control gr. who receives drug alone.ConclusionImparting philoshopy or spirituality helps in recovery of mental state.
P02-274 - The Robotics Intervention and the Clinical Approach Towards of New Paradigms?
Authors: Schweitzer M. , Puig-Verges N. 
Published: June 2010

For a long time robotics remained linked to the field of research because the reference to robotics still conveyed either illusions about anticipate events or fears and distrusts. The science of robotics does not limit itself any more to research laboratories and developed into multiple fields of social and economic activity; we assist to the emergence of robotics humanoid dealing directly with mankind and contributing to a constructive approach of knowledge.Trying a sanitary field approach with the intervention with autistic children and also with diverse forms of the handicap, robotics does not limit itself any more to interventions with productivity aim, but penetrated henceforth the field of the social practices as therapeutic steps, so contributing to the emergence of new purposes.In such a context, because she is intended for the recognition, in the identification and in the expression of the feelings, the robotics intervention presupposes an intentionality of interactivity communicational. The socio-adaptive approach underlies questions not only on the purpose of the clinical approach but also on the sense) attached to the clinical relation (phenomenological approach). The implications of robotics will constitute new social practices or they will contribute to the construction and to the diversification of clinical references,giving place to the emergence of new paradigms mobilized by the interactive approach and the cognitive reference.The Comparative Clinical Epistemology approach contributes to the different levels of analysis being deconstructed by the robotics intervention: the construction of a new cognition or the disappearance of the reference to individual experience.
P02-278 - Factors Determining Admission to Psychiatric Hospitalization in Psychotic Patients
Authors: de la Vega Sánchez D.C. , Sanchez Paez P. , Garcia Dorado M. , Duran Cristobal M.I. , Perez-Templado Ladron De Guevara J. , Regidor Bonafonte A. , Gomez Soler M.R. , Manzanero Estopiñan R. , Chinchilla Moreno A. 
Published: June 2010

ObjectivesOne of the most important prognostic factors in patients diagnosed with schizophrenia is the number of hospitalizations they need during their life. In this work we describe risk factors which determinate psychotic relapse.MethodsRetrospective review of the clinical histories of patients diagnosed with schizophrenia who needed hospitalization during the year 2008 using Hospital Ramon Cajal's history software. Data were analyzed using the SPSS software 15.0 version.Results-Socio-demographic: We collected a total of 57 patients, 60% were men and 77,2% were single who lived with their families. 52,8% only had Primary education and 14% had been to University. 38,6% were pensioner and 12,3% workers.-Risk factors: 54,4% had abandoned their medication, 7% had had recent modifications in their medication, and 35,1% received long acting antipsychotic. 42,1% were identified as substance users.-40,4% had been diagnosed with schizophrenia more than three years ago; 57,9% had had less than 3 previous hospitalizations, and 54,4% need hospitalization the previous year.ConslusionsMale under 30 years old have more risk of needing more hospitalizations. The main risk factor for suffering new psychotic episodes is the medication nonadherence, modifying medication only causes new episodes in few patients. Patients receiving long-acting antipsychotic agents suffer less psychotic relapse. Substance abuse among schizophrenia patients is a major complicating factor since almost half of the hospitalizations are related to it.
P02-279 - Assessement of Preventive and Promotion Activities in the Mental Health Area in Slovenia
Authors: Dernovsek M. , Sprah L. 
Published: June 2010

ObjectivesThe aim of the present study was to assess the preventive and promotion activities in the mental health area in 12 Slovenian regions. In addition, some of sociodemographic and health indicators related to increased probability of mental health problems were analysed in order to estimate the amount of preventive/promotion programmes in the regions with highest threats to mental health.Methods301 mental health services have been assessed according to their promotion and preventive activities in the mental health area. Services were surveyed according to their implemented activities, prevention types, funding sources, target groups, addressed risk and preventive factors and available staff at services.Results98% of assessed services were involved in one or more preventive and/or promotion activity. The selective primary prevention approach prevailed, whereas services mainly focused on major mood disorders and addiction. The most common types of activities were: individual / group counselling, lecture, workshop and media appearance, where the plan of support, interpersonal conflicts and organised lifestyle as addressed risk and protective factors predominated. In the preventive/promotion programmes were the most represented social workers, psychologists and volunteers. In the contrast with the scarcity of activities in Zasavska and Savinjska region, the most abundant choice of programmes was found in Osrednjeslovenska and Obalno-kraška region.ConclusionsOur study indicated that considerable differences appeared between Slovenian regions in the view of diversity and extent of preventive / promotion activities since availability and variety of this activities were particularly scarce in the regions with highest threats to mental health.
P02-288 - The Relation of Alexithymia, Depression and Obsessive-Compulsive Personality to Eating Disorder Tendency in Japanese Female Adolescents
Authors: Morita M. 
Published: June 2010

ObjectivesThis study examined how alexithymia subscales, depression and obsessive-compulsive personality(OCP) relate to eating disorder tendency (EDT) in non-clinical Japanese female adolescents.MethodsA self-report questionnaire survey was conducted on 393 Japanese female adolescents (273 undergraduates and 120 college students, mean age=19.9yrs, SD=1.4).ResultsA stepwise multiple regression analysis was conducted, indicating that “difficulty in identifying feelings”(DIF) (β=.17, p< .01) and “difficulty in describing feelings” (DDF) (β=−.15, p< .01), which are factors of alexithymia, depression (β=.30, p< .001) and OCP (β=.14, p< .05) predicted EDT. Depression had the strongest effect on EDT, with DIF the second strongest. Surprisingly, DDT had a significantly negative effect on EDT.ConclusionsFirst, prevention and therapy of eating disorder should focus on depression, difficulty in identifying feelings, and obsessive-compulsive personality. Second, one aspect of discontinuity between clinical and non-clinical females with high risk of eating disorder was implied: Non-clinical females with high risk of eating disorder may tend to describe at least superficial feelings frequently, if not deep or real feelings with introspection. Further, the possibility of describing may work as a preventive factor for non-clinical females with high risk of eating disorder against suffering from clinical eating disorder.Table 1:Results of stepwise multiple regression analysis predicting EDT βDepression,30***OCP,14*DIF,17**DDF−15**R2,17****p<.05 **p<.01 ***p<.001
P02-291 - The Influence of Group Psychotherapy to Crisis Frangibility and Coping Style in Community Residents
Authors: Weidong J. , Guoquan Z. , Wenli F. , Yunqing G. , Jun W. , Hong Z. , Hao C. 
Published: June 2010

ObjectiveTo understood the influence of group psychotherapy to crisis frangibility and coping style in community residents,seek the methods and value of community psychological coping intervention,and provide the basis of psychological theory and practice for the work of community mental health.MethodsThe scale of crisis frangibility and BCQ were employed to evaluate and compare the mental state before and after intervention.Results:1)Crisis frangibility of residents was negatively correlated with positive coping,positively correlated with negative coping.2)After group psychotherapy,scores of scale for crisis vulnerability and negative coping droped.3)Through the regression model analysis, the linear relationship between positive coping factor and the crisis vulnerable is closest.ConclusionGroup psychotherapy in community is a effective method to reduce resident's crisis frangibility,and the setup of experimental model has provided the theory and the practice basis for development psychology counseling in community.
P01-409 - Antiepileptic Drugs (AEDS) in the Treatment of Psychiatric Disorders
Authors: Kaufman K. 
Published: June 2010

ObjectivesThe pharmacologic interface between psychiatry and neurology is AEDs as they are utilized to treat both epilepsy and psychiatric disorders. Further, AEDs are commonly utilized to treat pain disorders. Thus, AEDs are primarily prescribed for treatment of psychiatric and pain disorders, not for treatment of epilepsy. The choice of which AEDs neurologists will utilize in treatment of epilepsy is most often premised on the classic benefits/risks/alternatives equation; however, consideration should be given to psychiatric co-morbidities and which AEDs might best serve patients in both maximizing seizure control and minimizing psychiatric symptoms as patients with epilepsy (PWE) have a 50-80% lifetime prevalence of psychiatric disorders with a three-to-five-fold increased risk of suicide compared to the general population. This overview of AED treatment of psychiatric disorders with inclusion of labeled and off-labeled uses can serve as a guide for neurologists and psychiatrists in better treating psychiatric co-morbidities in PWE.MethodsLiterature review.ResultsOf 16 AEDs reviewed, clinical studies have addressed > 30 possible uses; however only 5 AEDs (benzodiazepines, carbamazepine, valproate, lamotrigine, and pregabalin) have received FDA/EMEA psychiatric indications. Most studies are uncontrolled case reports, open-label case series, and underpowered randomized controlled trials with methodological flaws. Regardless of the limited approved indications and in some instances negative pivotal trials, AEDs continue to be utilized adjunctively or in monotherapy treatment for a plethora of psychiatric diagnoses.ConclusionsAEDs are pivotal in treating psychiatric co-morbidities in PWE. Further placebo-controlled (augmentation and monotherapy) parallel-arm research with active-comparators is required in this complex field.
P03-316 - Gender Differences in the Extrapyramidal Side Effects of Antipsychotic Medication
Authors: Anagnostakis K. , Dex G. 
Published: June 2010

IntroductionThe pathophysiology of extrapyramidal side effects of typical antipsychotic drugs and the role of gender as a risk factor is poorly understood.ObjectivesTo elucidate the role of gender and the oestrogen hypothesis in extrapyramidal side effect severity.AimsTo investigate gender differences in side effects of antipsychotic drugs and explore the role of oestrogen levels in side effect severity.Methods25 women and 23 men with a diagnosis of schizophrenia were examined for side effects using the Extrapyramidal Side Effects Rating Scale (ESRS), the Simpson Angus Rating Scale for Extrapyramidal Side Effects and the Abnormal Involuntary Movements Scale (AIMS).ResultsHigher antipsychotic doses and use of anticholinergics were noted in males.Women had higher ESRS scores and Simpson Angus scores. Men had higher mean scores for AIMS and the Barnes Akathisia Rating Scale. Age was significantly correlated with scores on ESRS, AIMS and Simpson Angus Rating Scale. There was a highly significant correlation between ESRS score and absence of a regular menstrual cycle. No association with age or antipsychotic dose was found between the groups. Women without a regular cycle scored significantly higher on Simpson Angus Rating Scale. Women with regular cycles scored significantly higher on Barnes Akathisia Rating Scale. There was no difference in AIMS score between the groups. No significant difference was found on any measure between women who were in the high and low oestrogen phases of the cycle.ConclusionsGender, age and the presence of a menstrual cycle should be considered when prescribing antipsychotic medication.
P03-318 - Paroxetine and Hyperprolactinemia: a Case Report
Authors: Arroita A. , Barreiro A. , Pacheco L. 
Published: June 2010

IntroductionParoxetine is a SSRI, widely used nowadays for treating diverse psychiatric pathologies, such as anxiety disorders, affective disorders… It is well known by clinician that paroxetine used is doses between 10-50 mg has evident benefits in the therapeutic process.Different adverse effects are commonly expected when using paroxetine, and some other side effects are considered rare, meaning that are shown in 1 or more every 10.000 patients but less than 1/1000.Materials and methodsComprehensive review of the scientific literature (Medline, Psychoinfo, Medex) on hyperprolactinemia secondary to SSRI treatments published over the last years.ResultsThis is a case report of a 32 year-old- female treated with paroxetine, suffering from panick attacks frequently in the context of an anxiety disorders. After 2 years she quited consuming cocaine in 2007.The patient after a couple of months being treated with paroxetine observes lactation, galactorrhea, and amenorrea.Analysis were done, in the beginning an increase in prolactine levels was found, after changing the treatment although prolactine levels were lowering the galactorrhea persisted in time.Before considering paroxetine as a factor, she started to be studied in a fertilization program, where she still is.ConclusionsGalactorrhea cases with tricyclic antidepressants, as well as with selective serotonin reuptake inhibitors are rarely reported. The observed lactation is presumed to be secondary to a drugmediated increase in prolactine levels. This is the report of a case of hyperprolactinemia and galactorrhea following treatment with paroxetine in a young female with an anxiety disorder.
P03-320 - Patients' Understanding of the Role of Anticholinergic Drugs in Their Treatment: Findings from an Outpatient Clinic in South-West Nigeria
Authors: Atilola O. , Makanjuola V. 
Published: June 2010

ObjectivesTo determine how informed psychiatric outpatients are about the role of anticholinergic drugs in their treatment.MethodsUsing a clinician-administered questionnaire designed by the authors; socio-demographic data and views about the role of Benzhexol in their treatments were obtained from all patients whose case records showed that they were currently prescribed Benzhexol.Results98 patients met inclusion criteria, mostly males (n=54; 55.1%). The respondents were predominantly in the age range 25 - 44years (n=67; 68.4%) and single (n=52; 53%). Two-thirds had no more than secondary education. Though more than half of respondents reported having being on their current combination of drugs for more than 1 year, 34% could not give the names of any of their medications. A third reported not knowing the role of Benzhexol in their treatment and of those who claimed to know, 64% (n=42) gave responses that reflected no understanding. Majority (n=31; 74%) of such responses were adjudged to have potentially deleterious implications on their health and outcome. There was no statistically significant association between educational status and knowledge of the role of Benzhexol in patients’ treatment. Only 18% reported ever being educated about the role of Benzhexol in their treatment.ConclusionThe study provides evidence that majority of the patients may not be well informed about important aspects of their treatment and that health workers may have neglected to educate them. It further calls for an urgent need to improve the patient-information aspects of service delivery in our clinics.
P03-322 - Effectiveness of Olanzapine in Patients with Schizofrenia
Authors: Bravo-Mehmedbasic A. , Kucukalic A. , Dzubur Kulenovic A. , Suljic E. 
Published: June 2010

IntroductionOlanzapine is a novel antipsychotic agent. It has a pleotrophic pharmacology and affects dopaminergic, serotonergic, muscarinic and adrenergic activities. The therapeutic advantage of recent antipsychotics (so-called atypical antipsychotics) has been attributed to alpha-2 adrenergic antagonist effects.ObjectiveThe aim of this study was to evaluated effectiveness of Olanzapine in patients with schizophrenia.MethodsStudy was designed for 8-week, observational study. 40 patients, both genders, aged 20-65 years, with diagnosed various types of schizophrenia were enrolled in the study as outpatient and inpatient setting. The patients had to have a total score ≥40 on Positive and Negative scale - two parts of the Positive and Negative Syndrome Scale (PANSS). The efficacy parameter was the percent of score difference between baseline and week 8 of therapy on two above-mentioned PANSS subscales. The difference was considered as significant improvement if decrease from the baseline was 20% or more.ResultsAll 40 enrolled patients completed the study. After the 8 weeks of treatment, 32/40 patients (80%) had clinically significant improvement of 20% or more decreased total PANSS score (Positive and Negative subscale). In 8/40 patients (20%) clinical improvement was also reported with < 20% decreased total PANSS score.ConclusionsIn this observational study olanzapine appears to be very good effectiveness in patients with schizophrenia.
P03-328 - Epilepsy in Individuals with Intellectual Disability in a Residential Centre in Dublin
Authors: Barrett E. , Mulryan N. , McLaughlin M. , Lane J. , Barrett C.M. 
Published: June 2010

ObjectivesThere are no large scale studies on Epilepsy in populations with Learning disability in Ireland. As many as one fifth of these clients have epilepsy. Aggressive treatment may lead to diminishing returns in terms of symptomatic control, while causing unwanted effects.1.We aimed to quantify rates of epilepsy, aetiology and anti- epileptic drug (AED) use in our population.2.To look at degree of disability and correlation with AED use.3.To look at management/ quality of life issues using a validated instrument.Methods:1.Medline review using search terms Intellectual OR Learning difficult* OR Mental Retard* AND Epilepsy.2.Simple questionnaire used to identify all clients with Epilepsy. Database analysed using SPSS analysis.3.11 cases selected for review looking at qualitative aspects, using Semi structured interview and GEOS scale.Results·210 patients found to have a history of epilepsy (42% of clients).·Multiple Aetiologies identified. Commonest known Aetiology: Trisomy 21.·Polypharmacy is common. Most commonly used AED: Sodium Valproate. Mean AED use: 1.595 (SD+- 1.077).·Clients with Trisomy 21 aged less than 40 tended to be on more medication (2.05, SD= +-1.38) than those over 40 years (1.43, SD= +- 0.89)·Greater concerns on qualitative measures regarding clients with refractory epilepsy or where epilepsy changed over time.ConclusionOur study highlights previously recognised changing patterns in aetiology of Learning Disability and also the changes over time in these clients. More study is required.
P03-331 - Neuroleptic Malignant Syndrome Associated with Olanzapine Therapy
Authors: Geka A.-E. , Avgeri V. , Psarra V. , Apatangelos D. , Garnetas C. 
Published: June 2010

ObjectivesNeuroleptic Malignant Syndrome (NMS) is a rare and potentially lethal adverse reaction generally associated with typical antipsychotics. Cardinal features include muscle rigidity, hyperthermia, mental status changes, elevated CPK levels.MethodsWe report on a patient receiving olanzapine, an atypical antipsychotic, who developed NMS.ResultsA 31 year-old male with a 5 year history of paranoid psychosis, was successfully treated with olanzapine 15 mg per day. He was also receiving oxcarbazepine for epilepsy (1200 mg/ day) and also suffered from spastic congenital paraparesis. He was almost asymptomatic for 4 years. At some point there was a recurrence of his illness with restlessness and aggressive behaviour. The patient decided to receive additionally 5 mg of olanzapine,without consulting psychiatrist. Soon he developed hyperthermia, hypertonia and confusion. He was initially admitted in a general hospital with leukocytosis and elevated CPK levels (1999 U/L). Other laboratory examinations were within normal limits. He was treated with ceftriaxone and parenteric fluids. After 48 hours he was improved and olanzapine was reinitiated (10 mg/day), and a few hours later he developed fever (40' C), hypertonia, dysphagia, confusion, CGS: 7/15 and elevated CPK levels (4900 U/LT). He was then transferred to the Intensive Care Unit and received treatment for NMS with bromocryptine and dantrolene sodium. His temperature returned to normal in two days and in 6 days he was physically stable. Twenty days later he received treatment for psychosis with low dose quetiapine.ConclusionNMS characterized by muscular rigidity and fever may rarely occur with atypical neuroleptics, such as olanzapine.